Manufacture

What lies ahead for Gene and Eva in 2019? Cell and gene therapies!

How a collaborative project aims to cut the cost of gene therapy

Serialization will certainly help in the battle against counterfeiters, but there are other steps that manufacturers can take.

It’s time for pharma to leave behind the highly energy-dependent and inflexible processes of the 20th century. Let’s “biologicalize” manufacturing.

Why use a huge manufacturing facility when biological medicines can be made in a suitcase?

The stem cell industry needs to embrace bioprocess control systems to develop consistent, high quality, and commercially viable bioprocesses.

Intensifying or simplifying your bioprocess can mean more product, shorter manufacturing times, or lower costs.

Rather than fearing the unknown, the concept of optionality can help you better manage it.

Single-pass TFF is a convenient means of reducing volumes, column sizes and hardware costs, as well as eliminating tank bottlenecks...

The 2018 Innovation Awards are here! From capsules, to software, to high-tech mass spectrometers; we celebrate the advances of the field.